Orchestra BioMed Holdings, Inc.
OBIO
$2.60
$0.051.96%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -19.36M | -18.76M | -16.16M | -15.43M | -15.98M |
Total Depreciation and Amortization | 81.00K | 83.00K | 84.00K | 76.00K | 74.00K |
Total Amortization of Deferred Charges | 46.00K | 46.00K | 31.00K | -- | -- |
Total Other Non-Cash Items | 3.35M | 3.00M | 3.87M | 2.29M | 2.63M |
Change in Net Operating Assets | 358.00K | -990.00K | -1.36M | -639.00K | 3.07M |
Cash from Operations | -15.53M | -16.62M | -13.54M | -13.70M | -10.21M |
Capital Expenditure | -34.00K | -112.00K | -106.00K | -68.00K | -107.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -602.00K | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 16.39M | 13.11M | -3.05M | 625.00K | 10.53M |
Cash from Investing | 16.36M | 13.00M | -3.75M | 557.00K | 10.42M |
Total Debt Issued | -- | -- | 15.00M | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 0.00 | 91.00K | 51.00K | 15.04M | 171.00K |
Repurchase of Common Stock | -428.00K | -387.00K | -550.00K | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -554.00K | -- | -- |
Cash from Financing | -428.00K | -296.00K | 13.95M | 15.04M | 171.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 401.00K | -3.91M | -3.34M | 1.89M | 389.00K |